ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,908Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 113

$546K Total Retail Price of All Prescriptions

Rank: 24 out of 113

639 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
22% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Montana
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 639 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

15% of this provider’s 639 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 11,339 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Montana
SIMVASTATIN 806 679 1 2
LISINOPRIL 673 610 2 3
OMEPRAZOLE 551 488 3 5
HYDROCHLOROTHIAZIDE 500 433 4 9
HYDROCODONE-ACETAMINOPHEN 432 333 S3 5 7
AMLODIPINE BESYLATE 412 378 6 4
LEVOTHYROXINE SODIUM 406 386 7 1
ATENOLOL 360 311 8 16
WARFARIN SODIUM 358 346 9 8
MELOXICAM 291 266 10 44
CITALOPRAM HBR 278 249 11 17
METOPROLOL SUCCINATE 274 268 12 10
FUROSEMIDE 243 223 13 6
LOSARTAN POTASSIUM 209 205 14 13
GABAPENTIN 206 166 15 18
ALENDRONATE SODIUM 197 197 16 22
FLUOXETINE HCL 185 162 17 31
ZOLPIDEM TARTRATE 179 167 18 19
ATORVASTATIN CALCIUM 173 162 19 15
POTASSIUM CHLORIDE 166 155 20 12
METFORMIN HCL 162 147 21 11
METOPROLOL TARTRATE 162 154 21 14
TAMSULOSIN HCL 157 132 23 24
GLYBURIDE 146 135 R 24 66
BENAZEPRIL HCL 134 105 25 46
POLYETHYLENE GLYCOL 3350 129 107 26 77
PREDNISONE 117 107 27 28
PRAVASTATIN SODIUM 114 98 28 23
PAROXETINE HCL 114 72 28 45
ALLOPURINOL 106 101 30 20
DOXAZOSIN MESYLATE 101 101 31 49
DONEPEZIL HCL 98 86 32 33
TRAZODONE HCL 81 80 33 41
TRAMADOL HCL 80 42 34 29
LOVASTATIN 78 78 35 53
EVISTA 75 75 36 119
CYMBALTA 73 53 37 37
DIOVAN 66 55 38 42
AMITRIPTYLINE HCL 65 61 R 39 58
PANTOPRAZOLE SODIUM 64 58 40 52
METHADONE HCL 63 28 S2 41 124
ACETAMINOPHEN-CODEINE 59 59 S3 42 129
MORPHINE SULFATE ER 58 45 S2 43 79
ADVAIR DISKUS 57 48 44 35
FLUTICASONE PROPIONATE 56 42 45 39
CIPROFLOXACIN HCL 56 55 45 63
FENTANYL 53 40 S2 47 43
LANTUS 53 39 47 38
PROAIR HFA 53 42 47 64
CARBIDOPA-LEVODOPA 53 53 47 73
GEMFIBROZIL 52 37 51 61
TRIAMTERENE-HCTZ 51 48 52 26
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 2, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.